A week ahead of the Medicare Payment Advisory Commission's (MedPAC) vote on its draft payment recommendations for fiscal 2017, the American Hospital Association (AHA) is sounding an alarm on a recommendation that would reduce Medicare payments to hospitals participating in the 340B drug pricing program by 10 percent of the average sales price.